| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
Autoimmune Testing Market Becomes the New Source of Growth for In VitroDiagnostics Companies Due to stagnating revenue growth and reimbursement pressures, in vitrodiagnostics (IVD) companies are looking at penetrating new niches such asautoimmune disease testing markets. The high double digit growth rate in thesegment for autoimmune diseases tests other than thyroid and rheumatoidarthritis is driving the autoimmune testing market in Europe. The variety ofpotential therapies for autoimmune diseases is expected to expand rapidly in thenext decade based on the efforts of leading pharmaceutical companies. Meanwhile,the awareness about and demand for autoimmune diagnostics are also likely toimprove significantly. This Frost & Sullivan strategic analysis service provides an overview andoutlook for the European autoimmune disease diagnostics market. The study hasbeen segmented into rheumatoid, thyroid and other autoimmune diseases. Theanalysis includes company profiles, technical challenges and growthrecommendations to improve revenue and market share. This study enablescompanies to align their positioning strategies to benefit from the changingmarkets and obtain maximum return on investment. An Ageing Population Creates Greater Market Opportunities for Participants The European population is slowly ageing with almost 17 per cent of thepeople in all EU countries aged 65 years and above. This sizeable potentialend-user market and its growing desire to be healthy and active is expected todrive this market. The trend towards integrated healthcare and a gradual shiftto proactive testing rather reactive diagnosis is likely to benefitthis market in long term. A team of researchers has discovered a genetic variation ? Single nucleotidepolymorphism (SNP) ? That doubles the risk for rheumatoid arthritis. "Thevariation is present in about 28 per cent of individuals with rheumatoidarthritis and 17 per cent of the general population, creating a vast market forthe autoimmune disease diagnostics market," notes the analyst of thisresearch. Market Poised for Exponential Growth The total European autoimmune disease diagnostics market was worth $440million in 2004 and is all set for a sizeable growth to reach almost $700.0million by 2011. One of the prime causes for this considerable growth has beenthe increasing government spending on healthcare, which is fuelling the growingdemand for better healthcare services. "Key initiatives by the respective governments in preventing diseasesare also expected to have a positive effect on the growth rate of the Europeanautoimmune disease diagnostics market," says the analyst. Frost & Sullivan Growth Partnership Service Based on extensive and in-depth research, real-world consulting work, and newtheories tested in hundreds of companies across many industries, Frost &Sullivan has evolved its Growth Partnership Services (GPS) program that providesestablished and emerging firms with powerful growth visions. Moving beyond tokenmission statements, GPS provides an actionable vision to growth consultingpartners by illustrating how key intelligence and strategic research based ondefined goals can guide day-to-day behavior and overall company direction. Thefoundation of Frost & Sullivans GPS includes: - Assisting companies to reach their full potential in the core business
- Providing growth strategies to help companies expand into relatedbusinesses
- Preemptively redefining the core business during market turbulence
- Applying the Frost & Sullivan framework to identify and address commonmistakes resulting from misaligned corporate strategies
- Recommending growth management strategies through continuous partnership
To maximize the potential for growth within a firms internal and externalenvironment, Frost & Sullivan consultants can facilitate the creation ofstrategic programs that deliver improved market success. Frost &Sullivans strengths lie in combining strategic understanding with marketexpertise and applying these with absolute commitment to its clients growth. TABLE OF CONTENTS
1 STRATEGIC ANALYSIS OF EUROPEAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET INEUROPE - Overview
- Research Scope and Methodology
- Research Scope and Methodology
- Market Segmentation
- Glosssary
- Introduction & Background
- Introduction
- Disease Prevalence
- Market Overview
- Main Applications of Diagnostic Tests
- Examples of Auto-antibodies and Their Significance
- Market Dynamics
- Market Challenges
- Market Drivers
- Proportion of people aged over 65 years
- Market Restraints
- Technology
- Detection Technologies
- IFA method
- ELISA method
- Technical Needs
- Regulations
- Competitive Landscape
- Competitive Landscape
- Eastern Europe
- Categories Of Companies
- Company Analysis
- Market Forecasts
- Assumptions
- Total Market Forecasts
- Revenue Sectoral Analysis
- Thyroid Disease Diagnostics
- Rheumatoid Disease Testing Forecasts
- Other Autoimmune Disease Tests Forecasts
- Strategic Analysis & Recommendations
- Strategic Recommendations
- Key Market Strategies
- Customer Priorities Trajectory
- Strategic Recommendations for Competitive Tiers
- Awards
- Frost & Sullivan Awards
- Technology Innovation Award
- Customer Service Innovation Award
- Product Line Strategy Leadership Award
- Brand Development Strategy Award
- Market Penetration Leadership Award
- Industry Participants
- Decision Support Database
- Decision Support Database
- About Frost & Sullivan
- Healthcare Team
- Our Capabilities
|
